ARCHIVES

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

This article is from The Cancer Letter archive.

Vol. 06 No. 45 | November 14, 1980

Download PDF Visit The Full Archive

Related Articles

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Human Genome Project publishes its final product.

October 22, 2004

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Retrospective Data Clean-up Can’t Help C225 Phase II Trial; Protocol Far Too “Fuzzy”

March 8, 2002